11/08 | Zealand Pharma Announces Financial Results for the First Half of 2022 | GL |
11/08 | Zealand Pharma Announces Financial Results for the First Half of 2022 | AQ |
08/08 | Updated notice to holders of ADSs regarding termination of Deposit Agreement | GL |
08/08 | Updated notice to holders of ADSs regarding termination of Deposit Agreement | AQ |
08/08 | Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.. | GL |
08/08 | Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.. | AQ |
04/08 | Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Seco.. | GL |
04/08 | Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Seco.. | AQ |
15/06 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | GL |
15/06 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | AQ |
10/06 | ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022 | GL |
10/06 | ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022 | AQ |
07/06 | Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual Ameri.. | GL |
07/06 | Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual Ameri.. | AQ |
03/06 | Zealand Pharma completes registration of capital increase | GL |
03/06 | Zealand Pharma completes registration of capital increase | GL |
03/06 | Zealand Pharma to Participate in Upcoming Investor Conferences | GL |
03/06 | Zealand Pharma to Participate in Upcoming Investor Conferences | AQ |
02/06 | ZEALAND PHARMA A/S : launches long-term incentive program for Zealand's Corporate Manageme.. | PU |
02/06 | Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Office.. | GL |
02/06 | Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Office.. | AQ |
01/06 | Zealand Pharma announces directed issue and private placement corresponding to approx. .. | GL |
01/06 | Zealand Pharma announces directed issue and private placement corresponding to approx. .. | GL |
31/05 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | GL |
31/05 | Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes As.. | GL |
31/05 | Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes As.. | GL |
25/05 | Zealand Pharma launches long-term incentive program for Zealand's Corporate Management .. | GL |
25/05 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | GL |
25/05 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | GL |
25/05 | Biotech Recovery Accelerates These Companies Benefit (IPA, SIGA, MNKD, INO, CTIC) | AQ |
24/05 | ZEALAND PHARMA A/S : Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pedi.. | PU |
20/05 | ZEALAND PHARMA A/S : Announces Asset Purchase Agreement with MannKind Corporation for V-Go.. | PU |
19/05 | Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatr.. | GL |
19/05 | Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatr.. | AQ |
17/05 | Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® I.. | GL |
17/05 | Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® I.. | AQ |
12/05 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | GL |
12/05 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | GL |
12/05 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | GL |
12/05 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | AQ |
12/05 | Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Developm.. | GL |
12/05 | Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Developm.. | GL |
10/05 | ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022 | GL |
10/05 | ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022 | AQ |
10/05 | Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company's Re.. | GL |
05/05 | Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Q.. | GL |
05/05 | Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Q.. | AQ |
22/04 | ZEALAND PHARMA A/S : launches long-term incentive program for Zealand's Board of Directors.. | PU |
22/04 | Transactions in Zealand Pharma A/S securities by persons discharging managerial respons.. | AQ |
20/04 | Zealand Pharma launches long-term incentive program for Zealand's Board of Directors fo.. | AQ |
11/04 | ZEALAND PHARMA A/S : AGM Minutes | PU |
08/04 | ZEALAND PHARMA A/S : Presentation from the Annual General Meeting | PU |
07/04 | CORRECTION : Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 202.. | GL |
07/04 | CORRECTION : Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 202.. | GL |
07/04 | ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, April 7 2022 | AQ |
06/04 | Zealand Pharma's Annual General Meeting 2022 | GL |
06/04 | ZEALAND PHARMA A/S : Voting Results | PU |
05/04 | ZEALAND PHARMA A/S : Amendment to Annual Report by Foreign Issuer (Form 20-F/A) | PU |
04/04 | Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference | AQ |
30/03 | ZEALAND PHARMA A/S : Appoints New Chief Executive Officer, Refocuses Strategy to Prioritiz.. | PU |
30/03 | Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize R.. | AQ |
15/03 | ZEALAND PHARMA : Significant Advancement of Clinical Pipeline and Building Commercial Mome.. | PU |
14/03 | ZEALAND PHARMA A/S : Notice to convene the Annual General Meeting of Zealand Pharma A/S (C.. | PU |
11/03 | CORRECTION : Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Com.. | GL |
11/03 | CORRECTION : Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Com.. | GL |
11/03 | Zealand Pharma - Significant Advancement of Clinical Pipeline and Building Commercial M.. | AQ |
10/03 | Zealand Pharma convenes its Annual General Meeting 2022 | GL |
10/03 | ZEALAND PHARMA : Significant Advancement of Clinical Pipeline and Building Commercial Mome.. | AQ |
03/03 | Zealand Pharma Hosts Conference Call on March 10 at 4 pm CET (10am ET) to Present Full .. | AQ |
25/02 | ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, 2022 | AQ |
15/02 | Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with C.. | AQ |
20/01 | Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide .. | AQ |
19/01 | ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, January 2022 | AQ |
12/01 | Scandion Oncology enhances its external communication | AQ |
03/01 | Zealand Pharma to Participate in H.C. Wainwright BIOCONNECT 2022 Conference | AQ |